Another possible source of TRD may be the “crunch” phenomenon: after anti-VEGF therapy, the response to reduced levels of VEGF may cause regression of new vessels and subsequent contraction of associated fibrovascular tissue, which causes the onset or worsening of TRD. The gene discussed is VEGFA; the disease is treatment resistant depression.